Rekovelle (follitropin delta)
- Region
- 🇪🇺 EU
- Active substance
- follitropin delta
- Company
- Ferring Pharmaceuticals A/S
- Status
- Authorised
- Therapeutic area
- Anovulation
- EU approval
- Mon 12 Dec 2016
- Application
- EMEA/H/C/003994
- ATC
- G03GA10
- Official record
- www.ema.europa.eu
Indication
Controlled ovarian stimulation for the development of multiple follicles in women undergoing assisted reproductive technologies (ART) such as an in vitro fertilisation (IVF) or intracytoplasmic sperm injection (ICSI) cycle.
Regulatory milestones
No milestones recorded in the last year.
Follow Rekovelle
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.